HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Unilever Lynx Ads Harmful To Children, Offensive To Women, Says U.K. Authority

This article was originally published in The Rose Sheet

Executive Summary

The U.K.’s advertising watchdog says that recent ads for Unilever’s Lynx brand deodorants and Lynx Excite shower gel breach advertising code, objectify women and are not appropriate for children to view. The ads must not appear again in their current form.

You may also be interested in...



In Brief

Synoia Technologies seeks “fastest” status for its anti-aging aesthetic device, P&G recalls select Crest & Scope oral-rinse products and Avon finishes refinancing. More news in brief.

Unilever Called Out For “Hypocrisy” Of Conflicting Dove, Axe Ad Campaigns

Unilever has come under fire for the seemingly contrary messages of Dove and Axe, two of its biggest brands and most buzzed-about advertising campaigns

Fenty Cleanser Performance Claims Supported, But Influencer Videos Need Disclaimers – NAD

A National Advertising Division review of claims by LVMH-owned Fenty Skin determined makeup- and dirt-removal representations were substantiated by a study and subject questionnaire, but demo videos from paid endorsers must include disclosures about material connections in accordance with FTC guidelines.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS017865

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel